Please assess the completion status of the following clinical trial:

Trial Title: Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male \& Females aged 65 and older~* Patients must meet the criteria for chronic idiopathic constipation for at least 12 weeks~* Patients must have had a colonoscopy within the past 5 years~* Patients must pass a balloon expulsion test at screening~* Patients must be able to comply and understand the use of a diary~Exclusion Criteria:~* Patients with a clinically significant medical condition that would interfere with the patient completing the trial~* Patients with loose stools at least once per week~* Patients with IBS~* Known allergies to the same class of drug and/or allergies to eggs~* Patients who require the use of manual maneuvers to have a bowel movement~Other protocol-defined inclusion/exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).